Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicentric, Real-world Investigation of Kappa Free Light Chains (KFLC) in Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS)

NCT07183020 is registered in ClinicalTrials.gov with Skripuletz, Thomas Prof. Dr. as lead sponsor.

NCT NCT07183020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07183020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicentric, Real-world Investigation of Kappa Free Light Chains (KFLC) in Multiple Sclerosis (MS) and Clinically Isolated Syndrome (CIS)
Lead sponsor
Skripuletz, Thomas Prof. Dr.
Phase
Observational
Overall status
Enrolling by invitation
Start date
October 27, 2022
Completion date
December 31, 2026
Enrollment
1,142 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinically isolated syndrome (cis), multiple sclerosis